Rohit Pal

14PUBLICATIONS
24CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsIndustrial microbiology (incl. biofeedstocks)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 09, 2026
Rational Design, Synthesis, Biological Evaluation, and In Silico Study of N-Cinnamamide/Benzamide-(4-(Substituted Phenyl)-6-(4-Cyclohexylphenyl)pyrimidin-2-Yl) Derivatives as EGFR Inhibitors Targeting EGFRWT, EGFRT790M, and EGFRL858R /T790M/C797S in NSCLC.

|Aug 31, 2026
Design, Synthesis, and Molecular Docking Studies of Coumarin-chalcone Conjugates as Selective TNF-α and Weak COX-2 Inhibitors with Efficacy as an Antioxidant.

|Jun 19, 2026
Pyrimidine derivatives as anticancer agents targeting kinases: design strategies, biological evaluation, and structure-activity relationship insights.

|Dec 03, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives.

Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal

|Apr 21, 2025
In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar

|Apr 19, 2025
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFRWT, EGFRT790M, and EGFRL858R/T790M/C797S in NSCLC: In Vitro and In Silico Evaluation.

Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli

Pageof 3

Frequent Collaborators

11 joint publications

Gurubasavaraja Swamy Purawarga Matada

4 joint publications

Ghanshyam Teli

4 joint publications

Lalmohan Maji

4 joint publications

Sindhuja Sengupta